Ultrasound-assisted gene therapy mitigates Leigh syndrome pathology
Brain · 2026
DOI: 10.1093/brain/awag026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Mathilde Faideau und 14 weiteren Autor:innen. Beteiligte Einrichtung: Grenoble Institut Neurosciences, University of Grenoble Alpes, Inserm, U1216, Grenoble 38000, France. Hauptthemen laut MEDLINE: Leigh Disease, Genetic Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: AFM-Telethon, United Mitochondrial Disease Foundation, Inserm.
Abstract (Originalsprache)
Leigh syndrome (LS) is a fatal neurometabolic disease caused by mutations in genes involved in mitochondrial energy harvesting. While there is currently no cure for this disease, pre-clinical studies showed that gene therapy can afford a therapeutic benefit in a relevant model of LS, the Ndufs4-knockout (KO) mouse. However, similar results need to be obtained using methods that can be translated into patients. Here, we combined two tools that are approved for clinical interventions. We used low-intensity focused ultrasound (FUS) to transiently permeabilize the blood–brain barrier and thereby facilitate the passage of an adeno-associated virus serotype 9 (AAV9) vector. This approach resulted in transgene expression in the brain and peripheral organs. When applied to 1-month-old Ndufs4-KO mice, this gene replacement strategy significantly extended the survival of the animals and ameliorated brain and cardiac function. These improvements were associated with the restoration of protein expression and mitochondrial function. These findings support the potential of combining FUS with AAV-mediated gene delivery to treat LS, and they warrant further clinical translation. This study also provides the first evidence that ultrasound-assisted gene replacement can exert a therapeutic effect in a condition affecting the CNS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grenoble Institut Neurosciences, University of Grenoble Alpes, Inserm, U1216, Grenoble 38000, France.
- Image Guided Therapy, Pessac 33600, France.
- Laboratory for Integrative and Systems Physiology, Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland.
- Metabolomic Platform, Université Paris-Saclay, Inserm US23/CNRS UAR 3655, Gustave Roussy, Villejuif 94805, France.
- Cell Biology and Metabolomics Platform, Gustave Roussy, Villejuif 94805, France.
- Université D'Orléans, LI2RSO, Orléans 45067, France.
ORCID-Profile: Sébastien Rigollet, Emmanuel L Barbier, Michael Decressac
Förderung
- AFM-Telethon
- United Mitochondrial Disease Foundation
- Inserm
- Agence Nationale de la Recherche
- EPFL
- European Research Council
- Swiss National Science Foundation
- Communaulté University Grenoble Alpes
Zitieren
APA
Faideau, M., Clément, R., Rigollet, S., Benegiamo, G., Cresson, C., Blot, B., Reynaud-Dulaurier, R., Yjjou, S., Aprahamian, F., Durand, S., Delalande, A., Barbier, E. L., Stupar, V., Auwerx, J., & Decressac, M. (2026). Ultrasound-assisted gene therapy mitigates Leigh syndrome pathology. Brain. https://doi.org/10.1093/brain/awag026
Vancouver
Faideau M, Clément R, Rigollet S, Benegiamo G, Cresson C, Blot B, et al. Ultrasound-assisted gene therapy mitigates Leigh syndrome pathology. Brain. 2026. doi:10.1093/brain/awag026
BibTeX
@article{Faideau2026,
author = {Faideau, Mathilde and Clément, Romain and Rigollet, Sébastien and Benegiamo, Giorgia and Cresson, Cassandra and Blot, Béatrice and Reynaud-Dulaurier, Robin and Yjjou, Sara and Aprahamian, Fanny and Durand, Sylvère and Delalande, Anthony and Barbier, Emmanuel L and Stupar, Vasile and Auwerx, Johan and Decressac, Michael},
title = {Ultrasound-assisted gene therapy mitigates Leigh syndrome pathology},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awag026}
}
EUVIMED